Ethyl 4-amino-1-piperidinecarboxylate | CAS:58859-46-4

We serve Ethyl 4-amino-1-piperidinecarboxylate CAS:58859-46-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Ethyl 4-amino-1-piperidinecarboxylate

Chemical Name:Ethyl 4-amino-1-piperidinecarboxylate
CAS.NO:58859-46-4
Synonyms:Ethyl 4-amino-1-piperidinecarboxylate
N-Carbethoxy-4-amino-piperidone
ethyl 4-aminopiperidine-1-carboxylate
N-Carbethoxy-4-amino-piperidone
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 256.5±33.0 °C at 760 mmHg
Molecular Formula C8H16N2O2
Molecular Weight 172.225
Flash Point 78.3±0.0 °C
 
Specification:
Appearance:Colorless to yellow liquid
Assay:≥98.0%
Moisture:≤0.5%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Domperidone.



Contact us for information like Ethyl 4-amino-1-piperidinecarboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-Carbethoxy-4-amino-piperidone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-Carbethoxy-4-amino-piperidone Use and application,N-Carbethoxy-4-amino-piperidone technical grade,usp/ep/jp grade.


Related News: Delta moved the date up after the US State Department warned that people should not travel to China due to concerns about the spread of coronavirus, which was first discovered in Wuhan, Hubei province, in December.Ethyldiisopropylamine manufacturer Delta moved the date up after the US State Department warned that people should not travel to China due to concerns about the spread of coronavirus, which was first discovered in Wuhan, Hubei province, in December.N-[[[2-(Aminooxy)ethyl]amino]sulfonyl]carbamic acid 1,1-dimethylethyl ester supplier Rigosertib, Onconova’s lead candidate, is a proprietary Phase 3 small molecule.5-Chloro-2-fluorotoluene vendor Rigosertib, Onconova’s lead candidate, is a proprietary Phase 3 small molecule.”So far, the finding is still under preliminary study, and a large number of experiments is needed to test if it is effective on patients,” it said, citing the WHO in saying that no proven effective drugs to prevent or treat the Wuhan coronavirus are currently available.